• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DBV Technologies SA

+ Add to Watchlist


24.9800 EUR 0.2400 0.97%

As of 05:08:49 ET on 09/18/2014.

Snapshot for DBV Technologies SA (DBV)

Open: 24.8500 Day's Range: 24.7600 - 24.9900 Volume: 8,961
Previous Close: 24.7400 52wk Range: 7.6600 - 26.2400 1-Yr Rtn: +216.20%

Stock Chart for DBV

No chart data available.
  • DBV:FP 24.9800
  • 1D
  • 1M
  • 1Y
Interactive DBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -1.4200
Est. EPS (EUR) (12/2014) -1.2640
Est. PEG Ratio -
Market Cap (M EUR) 383.87
Shares Outstanding (M) 15.37
30 Day Average Volume 39,333
Price/Book (mrq) 8.5501
Price/Sale (ttm) 88.6692
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for DBV

DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.

Pierre-Henri BenhamouChairman/CEO/Co-FounderDavid SchilanskyChief Financial Officer
Charles RubanChief Development OfficerBertrand DupontChief Industial Ofcr/Co-Founder
More Company Profile & Key Executives for DBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil